Verified Clinical Trials, the largest clinical trials database registry in North America, detected a disconcerting 16% attempted dual enrollment rate at a recent early phase unit startup. Verified Clinical Trials is an established and effective tool to stop the professional research subject from dual enrolling and causing issues with clinical trial safety and data quality. …
Verified Clinical Trials offers Medicare Secondary Payer act compliance capabilities for clinical trials. The trigger to initiate Medicare Secondary Payer Law adverse events reporting and ORMs (Ongoing Reporting for Medicals) is the date of incident of the research related adverse event or injury and NO payment or settlement is needed to initiate this required reporting. The Verified …
Verified Clinical Trials will attend and support The Avoca Group Quality Consortium May 9th in Princeton, New Jersey. Verified Clinical Trials is a company dedicated to improving clinical trial safety and data quality by preventing dual enrollment in clinical trials. Many of the world’s largest and most relevant clinical trial sponsors and CROs turn to …
Verified Clinical Trials has the solution to the complex and rigorous requirements surrounding the Medicare Secondary Payer Act in clinical trial research. While it is mandatory to collect personal demographic information and store this information in order to maintain compliance with the Medicare Secondary Payer Act, neither the sponsors nor the clinical research sites have the necessary tools to effectively …
Verified Clinical Trials (VCT) is pleased to announce their participation at the DIA in 2013 in Boston. Verified Clinical Trials will demonstrate their clinical trial database registry to stop the professional research subject from dual enrollment in clinical trials. In addition, Verified Clinical Trials will present their unique capabilities to handle reporting for the Medicare Secondary Payer …
1) Who what and when needs to be reported? All injuries (AEs & SAEs) that arise out of a clinical trial whether it be a device or drug trial that has a causal relationship to the study compound or device following review by the PI of the trial and the sponsor company. Initial required information …
